Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease

European Journal of Haematology

Volumn 72, Issue 2, 2004, Pages 135-139

  Møller, Holger Jon ^a   De Fost, Maaike ^b   Aerts, Hans ^c   Hollak, Carla ^b   Moestrup, Søren Kragh ^d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

CD163; Gaucher's disease; Haemoglobin scavenger receptor; Macrophage; Serum marker; Soluble receptor

Indexed keywords

BIOLOGICAL MARKER; CD163 ANTIGEN; CELL SURFACE RECEPTOR; CHITOTRIOSIDASE; DIFFERENTIATION ANTIGEN; ENZYME; IMIGLUCERASE; IMMUNOGLOBULIN; LEUKOCYTE ANTIGEN; MACROPHAGE DERIVED CHEMOKINE; MIGLUSTAT; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME THERAPY; GAUCHER DISEASE; HEPATOMEGALY; HUMAN; HUMAN TISSUE; IMMUNOLOGY; LYSOSOME STORAGE DISEASE; MACROPHAGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SOLUBILITY; SPLENECTOMY; SPLENOMEGALY; STATISTICAL SIGNIFICANCE;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GAUCHER DISEASE; HUMANS; MACROPHAGES; RECEPTORS, CELL SURFACE; REFERENCE VALUES;

EID: 0742269462     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0902-4441.2003.00193.x     Document Type: Article

References (24)

1. KRISTIANSEN M, GRAVERSEN J, JACOBSEN J, SONNE O, HOFFMAN HJ, LAW SKA, MOESTRUP SK. Identification of the hemoglobin scavenger receptor. Nature 2001;409: 198-201.
2. ZWADLO G, VOEGELI R, OSTHOFF KS, SORG C. A mAb to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. Exp Cell Biol 1987;55:295-304.
3. RITTER M, BUECHLER C, LANGMANN T, SCHMITZ G. Genomic organization and chromosomal localization of the human CD163 (M130) gene: a member of the scavenger receptor cysteine-rich superfamily. Biochem Biophys Res Commun 1999;260:466-474.
4. LAW SK, MICKLEM KJ, SHAW JM, ZHANG XP, DONG Y, WILLIS AC, MASON DY. A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily. Eur J Immunol 1993;9:2320-2325.
5. HÖGGER P, DREIER J, DROSTE A, BUCK F, SORG C. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid- inducible member of the scavenger receptor cysteine-rich family (CD163). J Immunol 1998;161:1883-1890.
6. SULAHIAN TH, HOGGER P, WAHNER AE et al. Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 2000;12:1312-1321.
7. BUECHLER C, RITTER M, ORSO E, LANGMANN T, KLUCKEN J, SCHMITZ G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro-and antiinflammatory stimuli. J Leukoc Biol 2000;67:97-103.
8. MØLLER HJ, PETERSLUND NA, GRAVERSEN JH, MOESTRUP SK. Identification of the hemoglobin scavenger receptor/ CD163 as a natural soluble protein in plasma. Blood 2002;99:378-380.
9. DROSTE A, SORG C, HÖGGER P. Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family. Biochem Biophys Res Commun 1999;256:110-113.
10. HINTZ KA, RASSIAS AJ, WARDWELL K, MOSS ML, MORGANELLI PM, PIOLI PA, GIVAN AL, WALLACE PK, YEAGER MP, GUYRE PM. Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163. J Leukoc Biol 2002;72:711-717.
11. COX TM, SCHOFIELD JP. Gauchers disease: clinical features and natural history. Baillieres Clin Haematol 1997;10:657-689.
12. BEUTLER E, GRABOWSKI GA. Gaucher disease. In: SCRIVER CR, BEAUDET AL, SLY WS, VALLE D, Eds. The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill, 1995:2641-2670.
13. GRABOWSKI GA, LESLIE N, WENSTRUP R. Enzyme therapy for Gaucher disease: the first 5 years. Blood Rev 1998;12: 115-133.
14. BOOT RG, HOLLAK CE, VERHOEK M et al. Glucocerebrosidase genotype of Gaucher patients in The Netherlands: limitations in prognostic value. Hum Mutat 1997;10:348-358.
15. ZIMRAN A, KAY A, GELBART T, GARVER P, THURSTON D, SAVEN A, BEUTLER E. Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients. Medicine (Baltimore) 1992;71:337-353.
16. MØLLER HJ, HYLTOFT PETERSEN P, REJNMARK L, MOESTRUP SK. Biological variation of soluble CD163. Scand J Clin Lab Invest 2003;63:15-22.
17. MØLLER HJ, HALD K, MOESTRUP SK. Characterisation of an enzyme linked immunosorbent assay for soluble CD163. Scand J Clin Lab Invest 2002;62:293-300.
18. HOLLAK CE, van WEELY S, van OERS MH, AERTS JM. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 1994; 93:1288-1292.
19. CHAMBERS JP, AQUINO L, GLEW RH, LEE RE, MCCAFFERTY LR. Determination of serum acid phosphatase in Gaucher's disease using 4-methylumbelliferyl phosphate. Clin Chim Acta 1977;80:67-77.
20. AERTS JM, HOLLAK CE. Plasma and metabolic abnormalities in Gaucher's disease. Baillieres Clin Haematol 1997;10:691-709.
21. BOOT RG, RENKEMA GH, VERHOEK M, STRIJLAND A, BLIEK J, de MEULEMEESTER TM, MANNENS MM, AERTS JM. The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem 1998;273: 25680-25685.
22. MORAN MT, SCHOFIELD JP, HAYMAN AR, SHI GP, YOUNG E, COX TM. Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K. Blood 2000;96:1969-1978.
23. MIZUKAMI H, MI Y, WADA R, KONO M, YAMASHITA T, LIU Y, WERTH N, SANDHOFF R, SANDHOFF K, PROIA RL. Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage. J Clin Invest 2002;109:1215-1221.
24. COX TM. Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses. J Inherit Metab Dis 2001;24(Suppl. 2):106-121.